1. 5‐Hydroxytryptamine type 7 receptor neuroprotection against NMDA‐induced excitotoxicity is PDGFβ receptor dependent. (13th February 2013) Authors: Vasefi, Maryam S.; Kruk, Jeff S.; Heikkila, John J.; Beazely, Michael A. Journal: Journal of neurochemistry Issue: Volume 125:Number 1(2013:Apr.) Page Start: 26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessing the impact of a cannabis course on pharmacy students' understanding, beliefs and preparedness regarding medical and recreational cannabis. (January 2022) Authors: Parihar, Vikas; Beazely, Michael A.; Katz, Laura; Dhami, Rita; Patterson, Lisa Laureen Journal: Canadian pharmacists journal Issue: Volume 155:Number 1(2022) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Canadian national consensus guidelines for naloxone prescribing by pharmacists. (November 2020) Authors: Tsuyuki, Ross T.; Arora, Vinita; Barnes, Mark; Beazely, Michael A.; Boivin, Michael; Christofides, Anna; Patel, Harsit; Laroche, Julie; Sihota, Aaron; So, Randy Journal: Canadian pharmacists journal Issue: Volume 153:Number 6(2020) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chronic early-life social isolation affects NMDA and TrkB receptor expression in a sex-specific manner. (24th August 2021) Authors: Gondora, Nyasha; Pople, Christopher B.; Tandon, Gorvie; Robinson, Morgan; Solomon, Eden; Beazely, Michael A.; Mielke, John G. Journal: Neuroscience letters Issue: Volume 760(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Frequently asked questions about naloxone: Part 1. (September 2021) Authors: Cid, Ashley; Patten, Alec; Grindrod, Kelly; Beazely, Michael A. Journal: Canadian pharmacists journal Issue: Volume 154:Number 5(2021) Page Start: 301 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Frequently asked questions about naloxone: Part 2. (November 2021) Authors: Cid, Ashley; Patten, Alec; Grindrod, Kelly; Beazely, Michael A. Journal: Canadian pharmacists journal Issue: Volume 154:Number 6(2021) Page Start: 385 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Frequently asked questions about naloxone: Part 3. (January 2022) Authors: Cid, Ashley; Patten, Alec; Grindrod, Kelly; Beazely, Michael A. Journal: Canadian pharmacists journal Issue: Volume 155:Number 1(2022) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Structure–activity relationship studies of benzyl‐, phenethyl‐, and pyridyl‐substituted tetrahydroacridin‐9‐amines as multitargeting agents to treat Alzheimer's disease. (11th July 2016) Authors: Osman, Wesseem; Mohamed, Tarek; Sit, Victor Munsing; Vasefi, Maryam S.; Beazely, Michael A.; Rao, Praveen P. N. Journal: Chemical biology & drug design Issue: Volume 88:Number 5(2016) Page Start: 710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The opioid crisis: Naloxone and pharmacists to the rescue. (September 2021) Authors: Beazely, Michael A.; Tsuyuki, Ross T. Journal: Canadian pharmacists journal Issue: Volume 154:Number 5(2021) Page Start: 289 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The status of naloxone in community pharmacies across Canada. (November 2020) Authors: So, Randy; Al Hamarneh, Yazid; Barnes, Mark; Beazely, Michael A.; Boivin, Michael; Laroche, Julie; Patel, Harsit; Sihota, Aaron; Smith, Tim; Tsuyuki, Ross T. Journal: Canadian pharmacists journal Issue: Volume 153:Number 6(2020) Page Start: 352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗